COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,033 Articles (22,627 medRxiv, 8,406 bioRxiv)

Most recent first Previous |  Page 2141: Articles 21401-21410  | Next

ACIS, A Novel KepTide™, Binds to ACE-2 Receptor and Inhibits the Infection of SARS-CoV2 Virus in vitro in Primate Kidney Cells: Therapeutic Implications for COVID-19
Roy, A., Gottschalk, G., Knox, K., Luan, C. H., Keating, J., Kesler, K.
10.1101/2020.10.13.337584 — Posted: 2020-10-14
The emergence of inter-clade hybrid SARS-CoV-2 lineages revealed by 2D nucleotide variation mapping
Wang, H.-L.
10.1101/2020.10.13.338038 — Posted: 2020-10-14
Methyltransferase-like 3 modulates severe acute respiratory syndrome coronavirus-2 RNA N6-methyladenosine modification and replication
Zhang, X., Hao, H., Ma, L., Zhang, Y., Hu, X., Chen, Z., Liu, D., Yuan, J., Hu, Z., Guan, W.
10.1101/2020.10.14.338558 — Posted: 2020-10-14
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives
Yan, K., Rawle, D. J., Le, T., Suhrbier, A.
10.1101/2020.10.13.338541 — Posted: 2020-10-14
Co-infection of influenza A virus enhances SARS-CoV-2 infectivity
Bai, L., Zhao, Y., Dong, J., Liang, S., Guo, M., Liu, X., Wang, X., Huang, Z., Sun, X., Zhang, Z., Dong, L., Liu, Q., Zheng, Y., Niu, D., Xiang, M., Song, K., Ye, J., Zheng, W., Tang, Z., Tang, M., Zhou, Y., Shen, C., Dai, M., Zhou, L., Chen, Y., Yan, H., Lan, K., Xu, K.
10.1101/2020.10.14.335893 — Posted: 2020-10-14
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Piepenbrink, M. S., Park, J.-G., Oladunni, F., Deshpande, A., Basu, M., Sarkar, S., Loos, A., Woo, J., Lovalenti, P., Sloan, D., Ye, C., Chiem, K., Erdmann, N. B., Goepfert, P. A., Truong, V. L., Walter, M. R., Martinez-Sobrido, L., Kobie, J. J.
10.1101/2020.10.14.339150 — Posted: 2020-10-14
Rapid Development of Neutralizing and Diagnostic SARS-COV-2 Mouse Monoclonal Antibodies
Chapman, A. P., Tang, X., Lee, J. R., Chida, A., Mercer, K., Wharton, R. E., Kainulainen, M. H., Harcourt, J. L., Martines, R. B., Schroeder, M., Zhao, L., Bryksin, A., Zhou, B., Bergeron, E., Bollweg, B. C., Tamin, A., Thornburg, N., Wentworth, D. E., Petway, D., Bagarozzi, D., Finn, M. G., Goldstein, J. M.
10.1101/2020.10.13.338095 — Posted: 2020-10-14
Coronavirus Disease-2019 Case, Death, and Testing Rates in the United States and Worldwide: Primary Data and Review
Schaefer, E. J., Geller, A. S., Diffenderfer, M. R., Dulipsingh, L., Wisotzkey, J., Kleiboeker, S. B.
10.1101/2020.10.13.20172957 — Posted: 2020-10-14
Post mortem pathological findings in COVID-19 cases: A Systematic Review
Hammoud, H., Bendari, A., Bendari, T., Bougmiza, I.
10.1101/2020.10.11.20210849 — Posted: 2020-10-14
Background and concurrent factors predicting non-adherence to public health preventive measures during the chronic phase of the COVID-19 pandemic
Pollak, Y., Shoham, R., Dayan, H., Gabrieli Seri, O., Berger, I.
10.1101/2020.10.13.20211904 — Posted: 2020-10-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).